Scientific Sessions 2025  /  Shifting Paradigms in Lipid Management for ASCVD Risk  /  Case Presentation for Discussion
Logo

American Heart Association

  61
  0

Final ID:

Case Presentation for Discussion

  • Grant, Jelani  ( Johns Hopkins Hospital , Parkville , Maryland , United States )
    • Author Disclosures:
    Jelani Grant: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Shifting Paradigms in Lipid Management for ASCVD Risk

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial

Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa

Lower LDL-C, for Longer? Defining the Optimal Timing and Intensity of Lipid-Lowering Therapy in Primary Prevention

Blumenthal Roger

More abstracts from these authors:
Cardiometabolic Risk Factor Control in the Progression from Pre–Heart Failure to Clinical Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study

Grant Jelani, Ndumele Chiadi, Wallace Amelia, Zhang Sui, Echouffo Justin, Hamo Carine, Nambi Vijay, Khan Sadiya, Selvin Elizabeth, Shah Amil

Incidentally Detected Coronary Calcium and the Burden and Severity of Cardiovascular-Kidney Metabolic Risk Factors

Pan Abigail, Zhang Sui, Martin Seth, Pagidipati Neha, Blumenthal Roger, Orringer Carl, Rangaswami Janani, Ndumele Chiadi, Grant Jelani

You have to be authorized to contact abstract author. Please, Login
Not Available